We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+4.43%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$2.26B
AUM Growth
+$119M
Cap. Flow
+$6.18M
Cap. Flow %
0.27%
Top 10 Hldgs %
23.68%
Holding
567
New
17
Increased
150
Reduced
169
Closed
110

Top Buys

Rank Stock Value
1
PRGO icon
Perrigo
PRGO
+$4.08M
2
VZ icon
Verizon
VZ
+$3.9M
3
OXY icon
Occidental Petroleum
OXY
+$2.83M
4
ASML icon
ASML
ASML
+$2.77M
5
BA icon
Boeing
BA
+$2.47M

Top Sells

Rank Stock Value
1
VOD icon
Vodafone
VOD
+$2.98M
2
GMED icon
Globus Medical
GMED
+$2.48M
3
NOV icon
NOV
NOV
+$2.12M
4
AGN
Allergan Inc
AGN
+$2.02M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.51M

Sector Composition

Rank Sector Weight
1 Healthcare 16.02%
2 Technology 11.84%
3 Industrials 11.53%
4 Financials 10.85%
5 Consumer Staples 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NKE icon
51
Nike
NKE
$61.9B
$13M 0.57%
335,548
+1,174
+0.4% +$43.7K
DHR icon
52
Danaher
DHR
$135B
$13M 0.57%
244,799
+1,860
+0.8% +$95.5K
EMR icon
53
Emerson Electric
EMR
$82.9B
$12.8M 0.57%
193,230
+3,018
+2% +$203K
ASML icon
54
ASML
ASML
$675B
$12.7M 0.56%
135,890
+32,140
+31% +$2.77M
KSU
55
DELISTED
Kansas City Southern
KSU
$12.6M 0.56%
116,939
+15,245
+15% +$1.57M
CL icon
56
Colgate-Palmolive
CL
$72.6B
$12.5M 0.55%
183,887
-1,392
-0.8% -$93.3K
TFC icon
57
Truist Financial
TFC
$63.2B
$12.4M 0.55%
313,611
+671
+0.2% +$25.7K
MKC icon
58
McCormick & Company Non-Voting
MKC
$13.4B
$12.3M 0.54%
344,106
-2,398
-0.7% -$85.6K
TEVA icon
59
Teva Pharmaceuticals
TEVA
$35.9B
$11.6M 0.51%
221,471
-29,611
-12% -$1.51M
TGT icon
60
Target
TGT
$62.1B
$11.5M 0.51%
198,572
-1,962
-1% -$115K
COST icon
61
Costco
COST
$415B
$11.1M 0.49%
96,755
+303
+0.3% +$34.8K
LMT icon
62
Lockheed Martin
LMT
$134B
$10.9M 0.48%
67,810
-444
-0.7% -$72.2K
MDY icon
63
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27B
$10.3M 0.46%
39,605
+443
+1% +$111K
NTRS icon
64
Northern Trust
NTRS
$22.2B
$10.3M 0.45%
160,378
-498
-0.3% -$30.7K
T icon
65
AT&T
T
$165B
$10.2M 0.45%
382,474
-1,662
-0.4% -$44.5K
KMB icon
66
Kimberly-Clark
KMB
$36.4B
$10.2M 0.45%
95,370
+628
+0.7% +$66.7K
ZTS icon
67
Zoetis
ZTS
$31.6B
$9.97M 0.44%
308,824
+21,140
+7% +$649K
DE icon
68
Deere & Co
DE
$170B
$9.71M 0.43%
107,236
+1,126
+1% +$104K
WBA
69
DELISTED
Walgreens Boots Alliance
WBA
$9.68M 0.43%
130,617
+370
+0.3% +$25.8K
ALL icon
70
Allstate
ALL
$66.9B
$9.65M 0.43%
164,425
+16,548
+11% +$954K
MON
71
DELISTED
Monsanto Co
MON
$9.54M 0.42%
76,515
-3,794
-5% -$444K
GWW icon
72
W.W. Grainger
GWW
$65.3B
$9.16M 0.4%
36,015
-1,275
-3% -$326K
C icon
73
Citigroup
C
$222B
$9.1M 0.4%
193,301
+29,012
+18% +$1.38M
MDLZ icon
74
Mondelez International
MDLZ
$77.7B
$9.02M 0.4%
239,913
+446
+0.2% +$16.3K
LUX
75
DELISTED
Luxottica Group
LUX
$8.87M 0.39%
153,022
-616
-0.4% -$34.9K

Similar funds

Gofen & Glossberg's Q2 2014 Portfolio in Review

As of Q2 2014, Gofen & Glossberg held 567 positions worth $2.26B, up 5.5% from $2.15B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Gofen & Glossberg's Q2 2014 filing shows 17 new, 150 increased, 169 reduced and 110 closed positions. Its largest new stake was Splunk Inc: 35,720 shares worth $1.98M. The largest sale was Vodafone, an estimated $2.98M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Industrials.

  • Gofen & Glossberg's largest Q2 2014 buy was Splunk Inc: 35,720 shares worth $1.98M.
  • Gofen & Glossberg added most to Perrigo in Q2 2014, an estimated $4.08M increase.
  • Gofen & Glossberg's biggest Q2 2014 reduction was Vodafone, cutting an estimated $2.98M.
  • Gofen & Glossberg fully exited BEAM INC COM STK (DE) in Q2 2014, selling an estimated $722K.
  • Gofen & Glossberg's ten largest holdings make up 24% of its $2.26B portfolio in Q2 2014.
  • Gofen & Glossberg opened 17 new positions and closed 110 in Q2 2014.
  • Gofen & Glossberg's portfolio value rose 5.5% quarter-over-quarter to $2.26B.

Based on Gofen & Glossberg's 13F filing for Q2 2014, filed 15 Jul 2014.